Cancer
Malignant Prostate Neoplasm
CI-CAN-00005927Explore in graph →
Top-level1,377 active trials24 approved drugs58 evidence items
- NCIt
- C7378
- ICD-10
- C61
- DOID
- 10283
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005927Explore in graph →
Clinical trials
5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (730)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03403595 | 177Lu-EB-PSMA617 in Patients With Metastatic Castration-resistant Prostate Cancer | unknown | Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | Jan 18, 2018 | clinicaltrials |
| NCT03356912 | CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy | unknown | Phase 2 | 220 | Consorzio OncotechOTHER | 1 | Dec 14, 2017 |
| NCT03356444 | Docetaxel Versus Abiraterone as First-line Treatment in mCRPC Patients With Intraductal Carcinoma of the Prostate | unknown | Phase 2 | 140 | West China HospitalOTHER | 0 | Nov 29, 2017 | clinicaltrials |
| NCT03351088 | Outcomes From a RCT Comparing Preventive Versus Delayed Ligation of DVC During Robot-assisted Radical Prostatectomy | unknown | N/A | 226 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Nov 22, 2017 | clinicaltrials |
| NCT03344822 | Place of 68Ga-PSMA-11 PET-CT in the Therapeutic Decision at the End of the Initial Staging for High Risk Prostate Cancer Patients(TePSMAG-68) | unknown | Phase 2 / Phase 3 | 33 | Central Hospital, Nancy, FranceOTHER | 1 | Nov 17, 2017 | clinicaltrials |
| NCT03098160 | Immunotherapy Study of Evofosfamide in Combination With Ipilimumab | unknown | Phase 1 | 69 | Threshold PharmaceuticalsINDUSTRY | 1 | Oct 30, 2017 | clinicaltrials |
| NCT03313726 | The Effect of ADT on PSMA-PET.(ADTPSMA) | unknown | N/A | 30 | Turku University HospitalOTHER_GOV | 1 | Oct 18, 2017 | clinicaltrials |
| NCT02724618 | Nanocurcumin for Prostate Cancer Patients Undergoing Radiotherapy (RT) | unknown | Phase 2 | 64 | Shahid Beheshti University of Medical SciencesOTHER | 1 | Oct 12, 2017 | clinicaltrials |
| NCT03207113 | Adoption, Acceptability, and Effectiveness of a Mobile Health App for Personalised Prostate Cancer Survivorship Care. | unknown | N/A | 610 | Centre for Global eHealth InnovationOTHER | 1 | Oct 12, 2017 | clinicaltrials |
| NCT02691169 | Integrated 18F-labelled PSMA Project | unknown | Early Phase 1 | 10 | St. Joseph's Healthcare HamiltonOTHER | 1 | Oct 9, 2017 | clinicaltrials |
| NCT03294122 | Predictors of Normal Tissue Response From the Microenvironment in Radiotherapy for Prostate and Head-and-neck Cancer(MICROLEARNER) | unknown | — | 400 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Oct 3, 2017 | clinicaltrials |
| NCT03264209 | Smart After-Care in Patients With Prostate Cancer | unknown | N/A | 200 | Ji Youl LeeOTHER | 1 | Oct 2, 2017 | clinicaltrials |
| NCT02844699 | A Multicenter Randomized Double-blind Placebo-controlled Pilot Study of Safety, Pharmacodynamics and Efficacy of Different Treatments of Immunotherapeutic Drug Mobilan (M-VM3) in Patients With Diagnosed Prostate Cancer | unknown | Phase 1 / Phase 2 | 24 | Panacela Labs LLCINDUSTRY | 1 | Sep 20, 2017 | clinicaltrials |
| NCT03285815 | Prostate Cancer - Localized Adenocarcinoma Proton Therapy | unknown | N/A | 156 | National Cancer Center, KoreaOTHER_GOV | 1 | Sep 18, 2017 | clinicaltrials |
| NCT02452307 | Peptide-specific Vaccination in HLA-A*02 Positive Patients With Biochemical Recurrence After Radical Prostatectomy | unknown | Phase 1 / Phase 2 | 36 | University Hospital TuebingenOTHER | 0 | Aug 17, 2017 | clinicaltrials |
| NCT02408497 | Use of Non-invasive 4D Ultrasound Clarity System in Prostate IMRT/RapidArc Therapy | unknown | — | 60 | National Cancer Centre, SingaporeOTHER | 1 | Aug 2, 2017 | clinicaltrials |
| NCT00851916 | CyberKnife Radiosurgery for Locally Recurrent Prostate CA | unknown | Phase 2 | 20 | CyberKnife Centers of San DiegoOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT01045148 | CyberKnife Radiosurgery for Localized Prostatic Carcinoma | unknown | Phase 2 | 258 | CyberKnife Centers of San DiegoOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT03223064 | Accuracy of Lymph Node Imaging in Prostate Cancer: PSMA PET-CT and Nano-MRI(MAGNIFY) | unknown | N/A | 40 | Radboud University Medical CenterOTHER | 1 | Jul 21, 2017 | clinicaltrials |
| NCT01830166 | Focal Therapy for Prostate Cancer - A Pilot Study of Focal Low Dose Rate Brachytherapy(FTPC) | unknown | N/A | 10 | British Columbia Cancer AgencyOTHER | 1 | Jul 13, 2017 | clinicaltrials |
| NCT01685125 | Abiraterone Acetate and Prednisone With or Without Dasatinib in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | unknown | Phase 2 | 96 | University of Southern CaliforniaOTHER | 1 | Jul 7, 2017 | clinicaltrials |
| NCT03201380 | Evaluation of the Practice of the TEP Choline at Patients With Prostate Cancer(TEPCholine) | unknown | — | 300 | Institut Paoli-CalmettesOTHER | 0 | Jun 28, 2017 | clinicaltrials |
| NCT03202381 | Phase IV Study to Evaluate Bone Mineral Density in No-bone Metastatic Prostate Cancer Treated With Degarelix(BLADE) | unknown | Phase 4 | 35 | Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaOTHER | 1 | Jun 28, 2017 | clinicaltrials |
| NCT02605226 | Cryoablation Therapy or Radiotherapy Therapy for Stage III Prostate Cancer(CRYO-PCA-III) | unknown | N/A | 240 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jun 12, 2017 | clinicaltrials |
| NCT02615223 | Endocrine Therapy With or Without Cryoablation for Stage IV Prostate Cancer(CRYO-PCA-IV) | unknown | N/A | 120 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Jun 12, 2017 | clinicaltrials |
| NCT03174054 | The Value of PSMA-PET Compared With Multi-parametric MRI in the Detection Prostate Lesions | unknown | — | 70 | Assuta Medical CenterOTHER | 0 | Jun 2, 2017 | clinicaltrials |
| NCT03164837 | 68Ga-NOTA-RM26 PET/CT in Prostate Cancer Patients | unknown | Phase 1 | 30 | Peking Union Medical College HospitalOTHER | 1 | May 24, 2017 | clinicaltrials |
| NCT02278679 | Digital Rectal Exam Proficiency Tool(DiRECT) | unknown | — | 410 | University of VirginiaOTHER | 1 | May 18, 2017 | clinicaltrials |
| NCT03137186 | Repurposing Metformin as Anticancer Drug: in Advanced Prostate Cancer(Mansmed) | unknown | Phase 2 | 120 | Mansoura UniversityOTHER | 1 | May 2, 2017 | clinicaltrials |
| NCT03124615 | Effect of Enzalutamide Dose Reduction on Fatigue, Cognition, and Drug Trough Levels in Patients With Prostate Cancer(EFFECT) | unknown | Phase 2 | 47 | Macquarie University, AustraliaOTHER | 1 | Apr 24, 2017 | clinicaltrials |
| NCT02016040 | Focal Therapy Using HIFU for Localised Prostate Cancer | unknown | Phase 2 / Phase 3 | 25 | Jewish General HospitalOTHER | 1 | Apr 19, 2017 | clinicaltrials |
| NCT02577627 | Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOC | unknown | — | 5,000 | Optimata Ltd.INDUSTRY | 1 | Apr 4, 2017 | clinicaltrials |
| NCT03085966 | Autologous Immune Cell Therapy in Combination With LHRH-a in Patients With mCRPC | unknown | Phase 1 / Phase 2 | 30 | Shanghai AbelZeta Ltd.INDUSTRY | 1 | Mar 21, 2017 | clinicaltrials |
| NCT02524860 | Targeted Prostate Biopsy Using a Novel MRI-Ultrasound Fusion Device | unknown | N/A | 30 | Focal Healthcare Inc.INDUSTRY | 1 | Mar 16, 2017 | clinicaltrials |
| NCT03061760 | Effects of Urinary Bladder Hypertrophy on Urge Urine Incontinence After Radical Prostatectomy | unknown | — | 250 | Collegium Medicum w BydgoszczyOTHER | 0 | Feb 23, 2017 | clinicaltrials |
| NCT03050996 | Retrograde Perfusion Sphinterometry and Autologous Sling to Improve Urinary Continence in Robotic Radical Prostatectomy | unknown | — | 50 | Istituto Auxologico ItalianoOTHER | 1 | Feb 13, 2017 | clinicaltrials |
| NCT01437085 | A Study to Measure Needle Bending and Changes in Prostate Shape During a Prostate Seed Implant | unknown | — | 25 | AHS Cancer Control AlbertaOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT03031613 | Effects of PEEP on Intracranial and Intraocular Pressure in Robot-assisted Laparoscopic Radical Prostatectomy | unknown | N/A | 50 | Gangnam Severance HospitalOTHER | 1 | Jan 25, 2017 | clinicaltrials |
| NCT01555086 | Prospective Study to Compare a Limited Versus Extended Pelvic Lymphadenectomy During Prostatectomy(SEAL) | unknown | N/A | 500 | Association of Urologic Oncology (AUO)OTHER | 1 | Jan 24, 2017 | clinicaltrials |
| NCT03029533 | Phase 1 Study to Evaluate the Pharmacokinetics and Safety Following SC Administration of DWJ108J in Patients With Prostate Cancer | unknown | Phase 1 | 44 | Daewoong Pharmaceutical Co. LTD.INDUSTRY | 0 | Jan 24, 2017 | clinicaltrials |
| NCT03013712 | A Clinical Research of CAR T Cells Targeting EpCAM Positive Cancer(CARTEPC) | unknown | Phase 1 / Phase 2 | 60 | First Affiliated Hospital of Chengdu Medical CollegeOTHER | 1 | Jan 6, 2017 | clinicaltrials |
| NCT02934685 | IG-VMAT for Localized Prostate Cancer | unknown | Phase 3 | 60 | Beijing HospitalOTHER_GOV | 1 | Nov 18, 2016 | clinicaltrials |
| NCT02964351 | microRNA Profiles Identification in Adeno Carcinoma Prostate Cancer | unknown | — | 120 | Assuta Medical CenterOTHER | 0 | Nov 16, 2016 | clinicaltrials |
| NCT02265159 | Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer | unknown | Phase 2 / Phase 3 | 100 | University of ZurichOTHER | 1 | Oct 27, 2016 | clinicaltrials |
| NCT02721784 | Serial mpMRI (Multi Parametric Magnetic Resonance Imaging) Scanning in Prostate Cancer After Androgen Deprivation Therapy and RadioTherapy(SMART) | unknown | Phase 1 / Phase 2 | 10 | University College, LondonOTHER | 1 | Oct 26, 2016 | clinicaltrials |
| NCT02545881 | Development and Validation of Novel MRI Methods for the Detection of Prostate Cancer Aggressiveness(PROAG) | unknown | — | 200 | Turku University HospitalOTHER_GOV | 1 | Oct 19, 2016 | clinicaltrials |
| NCT02440802 | Evaluation and Predictive Value of Genetic Polymorphisms in the Management of Hormonal Treatment of Prostate Cancer(Feel+) | unknown | — | 250 | Cliniques universitaires Saint-Luc- Université Catholique de LouvainOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT02935816 | Localising Occult Prostate Cancer Metastases With Advanced Imaging TEchniques(LOCATE) | unknown | — | 130 | University College, LondonOTHER | 1 | Oct 18, 2016 | clinicaltrials |
| NCT02935023 | Carbon Ion Radiotherapy in Treating Patients Undergoing Systemic Therapy for Oligo-metastatic Prostate Cancer | unknown | Phase 2 | 47 | Shanghai Proton and Heavy Ion CenterOTHER | 1 | Oct 17, 2016 | clinicaltrials |
| NCT01354171 | Active Surveillance Magnetic Resonance Imaging Study(ASIST) | unknown | Phase 3 | 250 | Canadian Urology Research ConsortiumOTHER | 1 | Oct 14, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Jan 18, 2018source: clinicaltrials